Rize Oncology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May '25 May 22, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Debt / Equity Ratio	-	-	-	-	-	-1.57
Net Debt / Equity Ratio	-0.56	-1.05	-0.99	-0.97	-1.14	-0.99
Quick Ratio	22.51	13.98	35.33	20.54	0.84	0.37
Current Ratio	41.21	14.35	36.56	22.24	1.74	0.37
Return on Equity (ROE)	-191.89%	-44.40%	-42.64%	-170.34%	-4122.37%	-
Return on Assets (ROA)	-117.50%	-28.28%	-27.84%	-92.74%	-492.06%	-153.75%
Return on Capital Employed (ROCE)	-448.40%	-53.10%	-54.50%	-92.50%	-1041.10%	92.50%
Buyback Yield / Dilution	-68.71%	16.52%	-7.75%	-20.45%	-32.93%	-3729.11%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.